Notes
Slide Show
Outline
1
Neuroendocrine Imbalance in Patient Care
    • Leo Galland M.D.


2
CLINICAL VISION IS
WHAT THE DOCTOR SEES
3
Conventional Medical Vision
  • People become sick because they develop diseases.
  • The doctor looks for the disease that occupies the patient.
  • The name of this disease becomes the diagnosis and the basis for treatment.
4
Another Way of Seeing
  • People become sick because of disharmonies and imbalances, which  may involve:
  •     Social relationships, environmental assaults,     problems of diet, lifestyle, behavior and belief systems, and disturbances in the flow of energy and information within the individual.
  • The healer’s job is to identify and help the patient correct these.
5
Central Systems Mediate Functions Needed for Coordinated Behavior of the Whole Organism
  • Systems relating brain and body
  • -Autonomic nervous system
  • -Neuroendocrine system
  • -Neuroimmune system
  • Systems within the brain
  • -Specific and diffuse transmitter systems
  • -Distributed systems


6
Central Systems Are Difficult to Localize and Measure
  • Their output may be too widespread to characterize adequately.
  • Their actions may persist for days, months or years.
  • Although behaviors generated by central systems can be observed and classified, their neural substrates may be elusive.
7
Central Systems Interact with One Another Continuously
  • Immune responses alter neuroendocrine function.
  • Endocrine responses alter neuroimmune function.
  • Neuroendocrine responses alter autonomic nervous system function.
8
Neuroendocrine Regulation Maintains Homeostasis in Response to Stressors
  • Prolonged stress causes allostasis, a new equilibrium significantly different from the resting state:  levels of important physiologic mediators are altered.
  • Neuroendocrine imbalance is one manifestation of allostasis.
9
Neuroendocrine Imbalance
  • Is a disruption in the flow of information among cells and between organs.
  • Is not a specific disease but may complicate many different diseases.
10
Glands and Hormones
  • GH, PRL, ACTH, TSH, FSH, LH
  • Arginine vasopressin, oxytocin, endorphins, enkephalins
  • Melatonin
  • T4, T3, calcitonin
  • PTH
  • Anterior pituitary


  • Posterior pituitary/ neurointermediate lobe


  • Pineal
  • Thyroid
  • Parathyroid
11
Glands and Hormones
  • ANF
  • Glucocorticoids, mineralocorticoids, androgens
  • epinephrine, norepinephrine


  • Renin, calcitriol
  • Vitamin D
  • Heart
  • Adrenal cortex



  • Adrenal medulla


  • Kidney
  • Skin
12
Glands and Hormones
  • Angiotensin
  • Insulin, glucagon
  • CK, VIP, bombesin, somatostatin
  • Estrogen, progesterone testosterone
  • Cytokines


  • Liver/lung
  • Pancreas
  • GI tract


  • Gonads


  • Lymphocytes, macrophages


13
Hypothalamic Neuropeptides
  • CRF
  • GnRF
  • TRH
  • GHRF, GHIF
  • PRF, PIF
  • Neuropeptide Y
  • Leptin
14
Classic Neurotransmitters
  • Catecholamines: DA, NE, EPI
  • Indoles: 5 HT, Melatonin
  • ACh
  • Amino acids: GABA, Glutamate, Aspartate
15
Biological Rhythms Reflect Anticipatory Homeostasis
  • Dark increases melatonin which induces sleep.
  • Rest increases PRL which increases REM sleep.
  • CRH, vasopressin and neuropeptide Y increase during sleep, preparing for increased brain activation and food-searching behaviors on awakening.


16
Sleep Patterns Are Determined by the Immune System
  • IL-1 induces Stage 4 sleep and stimulates the HPA axis.
  • In health, IL-1 production is cyclic.
  • It is stimulated by muramyl peptides derived from normal gut microflora.
  • It is inhibited by glucocorticoids.


17
REGULATORY PATHWAYS
  • NE enhances hypothalamic CRH.
  • Serotonin enhances ACTH secretion:
  • 5HT deficits impair HPA output.
  • NE neurons stimulate TSH:
  • Adrenergic deficits impair HPT responses. Thyroid deficit impairs adrenergic function.
18
Vasopressin and the Brain
  • VP mimics/enhances CRH effects. Under stress, some VP neurons produce CRH.
  • Testosterone increases VP synthesis; some testosterone-induced aggressive behaviors may be VP mediated.
  • NE increases CRH and VP production.
  • Glucocorticoids decrease CRH/VP production in the hypothalamus, not the amygdala.



19
INFLAMMATORY MEDIATORS MAY ALTER NEUROENDOCRINE FUNCTION
  • CYTOKINES
  • PROSTANOIDS
  • ENZYMES
  • MONOAMINES
  • VARIOUS PEPTIDES
20
EFFECTS OF INFLAMMATION
  • Altered protein synthesis
  • Neuroendocrine changes
  • Hematopoietic changes
  • Metabolic changes
  • Altered micronutrient levels: zinc, iron , copper, magnesium, retinol, glutathione
21
NEUROENDOCRINE EFFECTS
  • Fever, somnolence, anorexia
  • HPA axis stimulation
  • Increased arginine vasopressin secretion
  • Inhibition of IGF-1 synthesis
  • Increased adrenal catecholamine secretion
22
Autonomic Dysregulation
  • Neurally-mediated hypotension
  • Sympathetic hyperreflexia
  • Parasympathetic hypertonus
  • Drug induced
  • Denervation
  • Classic dysautonomias


23
Tests of the HPA Axis
  • Serum cortisol at 800, 1600, 2400
  • Cortisol response to ACTH
  • ACTH response to CRH
  • Serum DHEA-S
  • 24 hour urine for cortisol, DHEA
  • Dexamethasone suppression


24
Tests of the HPT Axis
  • T4, T3, TSH (third generation)
  • TSH response to TRH
  • Urinary excretion of T3, T4 ?
25
References for Neuroendocrine Testing
  • Dons RF: Endocrine and Metabolic testing Manual, CRC Press, Third Edition 1998.
  • Svirbely JR & Sriram MG, The Medical Algorithms Project.
  • www.medal.org.ar/chapters/index.html
  • (Chapter 13)
26
Clinical Indicators
  • Fatigue (conditional, fluctuating)
  • Exercise intolerance
  • Temperature intolerance (hot/cold)
  • Abnormal temperature control
  • Disordered patterns of sleep, appetite
  • Difficulty losing/gaining weight
  • Cardiac symptoms
27
Physical Findings
  • Temperature, pulse, blood pressure
  • Orthostatic change in pulse, blood pressure
  • Pulse change with forceful handgrip


28
Women with PMS Have Impaired Serotonin Circuits
  • Women with PMS have an impaired serotonin response to tryptophan and a blunted cortisol response to serotonin.
  • Impoved function of serotonin-dependent pathways improves premenstrual symptoms.
29
Impaired Utilization of Tryptophan in Women with PMS
  • Intravenous tryptophan produced a smaller elevation of whole blood serotonin in women with PMS than in controls.
  • This effect occurred only during the luteal phase.
  • Does it explain the carbohydrate cravings that are so common at this time?
30
The HPT Axis Is Often Abnormal in Depression
  • 10% of hospitalized patients are hypothyroid (TSH stimulation).
  • For others, TSH response to TRH is blunted, due to abnormal neurotransmission.
  • T3 is an effective anti-depressant, whatever the neuroendocrine responses.
31
The HPA Axis Shows Loss of Negative Feedback in People with Depression
  • Urine free cortisol is elevated, especially when stressors cannot be controlled.
  • Diurnal pattern may be disrupted, with increased PM cortisol secretion.
  • Dexamethasone suppression is blunted.
  • Spinal fluid CRH is elevated (also in OCD and post-traumatic stress disorder).


32
The Amygdala and Allostasis
  • Receives information from all neocortical sites and visceral input from brainstem.
  • Involved in emotional memory.
  • CRH production here is up-regulated by glucocorticoids.
  • Increased activation occurs in depression.
  • CRH in the brain induces fear, withdrawal.
33
EFAs and Depression
  •  Impaired synaptic function due to a deficit of omega-3 essential fatty acids (EFAs) may contribute to the pathogenesis of CNS disturbances in depression.
  • (1)    Maes M. Et al. Psychiatry Res (1998).
  • (2)   Peet M et al. Biol psychiatry (1998).
  • (3)   Adams PB. Lipids (1996).


34
The HPA Axis in CFIDS
  • Cortisol response to exercise is blunted.
  • ACTH response to CRH is blunted.
  • As if patients are withdrawing from exogenous steroids.
  • DHEA response to ACTH is impaired.
  • Low dose cortisone improves symptoms but aggravates HPA suppression.


35
T-Helper Cells in CFS Patients are Ultrasensitive to Glucocorticoids
  • CD-4 lymphocytes from patients produce less gamma-interferon than controls.
  • Inhibition of cell proliferation and production of gamma-interferon or IL-4 was produced at 5-10% of the dose of dexamethasone required for controls.
36
Hypotension in CFIDS
  • Delayed orthostatic hypotension is common.
  • Fludrocortisone was ineffective in a controlled study.
  • Sodium loading relieves symptoms, perhaps by stimulating vasopressin synthesis.
37
Oral NaCl Improves CFS Symptoms
  • One third of CFS patients had abnormal tilt table tests.
  • Sustained release NaCl, 1200 mg daily for 8 weeks improved tilt table responses and symptoms in 50% of these.
  • Non-responders  had low plasma renin activity.
38
Desmopressin improves HPA Response to CRH in CFS
  • Patients with CFS have an impaired ACTH and cortisol response to CRH.
  • Desmopressin (a vasopressin analogue) restores this to normal.
39
Clinical Approaches
  • Symptom analysis:
  • - Fatigue (conditional, fluctuating)
  • - Exercise intolerance
  • -Temperature intolerance
  • Physical findings:
  • -Unstable blood pressure
  • -Inappropriate temperature



40
Dietary Influences
  • High protein, low carbohydrate diets may decrease serotonin availability and deplete volume.
  • Omega-3 EFA deficit may impair serotonin activity.
  • Low sodium, high water intake depresses vasopressin synthesis.
41
Substances That May Enhance HPA Activity

  • Sodium
  • Phosphatidyl serine
  • Siberian ginseng
  • Maca
  • Serotonin enhancers
42
Substances That May Inhibit HPA Activation
  • Water
  • Benzodiazepines
  • Exogenous steroids
43
When Your Favorites Treatments Don’t Work…
  • They may have undesirable neuroendocrine effects.
  • More time may be required because the effects of central systems can be prolonged.